Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Certified by Founder
Lodge
SOLASTA Bio
start up
United Kingdom
- Glasgow
- 12/04/2023
- Pre Series A
- $4,967,000
SOLASTA Bio is an ambitious bioinsecticides start up with a unique proposition: nature-inspired small molecule insect control products for the global agricultural market. We are a small but passionate and world-leading team - join us!
- Industry Biotechnology Research
- Website N/A
- LinkedIn https://www.linkedin.com/company/solasta-bio/
Related People
Shireen DaviesFounder
United Kingdom -
East Dunbartonshire, Scotland
Founder CEO of SOLASTA Bio, developing innovative peptide insecticides for global agriculture.
A recent UKRI BBSRC Royal Society of Edinburgh Enterprise Fellow with a leading track record in technology innovation and fundraising.
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)